• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

    12/4/24 7:00:00 AM ET
    $AEMD
    $ASPI
    $ATRA
    $BENF
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials
    Get the next $AEMD alert in real time by email

    MIAMI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 77th Emerging Growth Conference on December 4 & 5, 2024.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter.



    Day 1


    December 4, 2024

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    9:40 – 10:10

    ATRenew Inc. (NYSE:RERE) 

    Keynote speakers: Jessie Jin, Investor Relations Manager, & Jeremy Ji, Director of Corporate Development & Investor Relations

    10:15 – 10:45

    Beneficient (NASDAQ:BENF)

    Keynote speaker: Brad K. Heppner, CEO

    10:50 - 11:20

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    11:25 - 11:55

    Brenmiller Energy, Ltd. (NASDAQ:BNRG)

    Keynote speaker: Nir Brenmiller, COO

    12:00 – 12:30

    West Red Lake Gold Mines Ltd. (OTCQB:WRLGF) (TSXV:WRLG)

    Keynote speaker: Gwen Preston, Vice President, Communications

    12:35 - 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Thomas Larsen, CEO & Chairman, & Dr. William N. Pearson, Executive Vice President of Exploration

    1:10 - 1:40

    Luca Mining (OTCQX:LUCMF) (TSXV:LUCA)

    Keynote speaker: Dan Barnholden, CEO

    2:40 – 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 – 3:05

    Viomi Technology Co., Ltd. (NASDAQ:VIOT)

    Keynote speakers: Claire Ji – IR & Finance, and Sam Yang, Head of Capital and Strategy

    3:10 – 3:20

    Realbotix Corp. (OTCQB:XBOTF) (TSXV:XBOT)

    Keynote speaker: Andrew Kiguel Co-Founder, CEO

    3:25 - 3:35

    Icon Energy Corp. (NASDAQ:ICON)

    Keynote speakers: Ismini Evangelia Panagiotidi, CEO, Chairwoman & Dennis Psachos, CFO

    3:40 – 3:50

    NurExone Biologic Inc. (OTCQB:NRXBF) (TSXV:NRX)

    Keynote speaker: Dr. Lior Shaltiel, CEO

    3:55 – 4:05

    Pure Cycle Corporation (NASDAQ:PCYO) 

    Keynote speaker: Mark Harding, President

    4:10 – 4:20

    MetaVia, Inc. (NASDAQ:MTVA)

    Keynote speakers: Hyung Heon "HH" Kim, President / CEO, & Marshall H. Woodworth, CFO

    4:25 – 4:35

    Aethlon Medical, Inc. (NASDAQ:AEMD)

    Keynote speakers: Jim Frakes, Acting CEO and CFO & Steven LaRosa, Chief Medical Officer

    4:40 – 4:50

    Sky Harbour Group Corporation (NYSE:SKYH)

    Keynote speakers: Tal Keinan, Founder and CEO & Francisco X. Gonzalez, CFO



    Day 2


    December 5, 2024

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    U Power Limited (NASDAQ:UCAR)

    Keynote speaker: Paul Li – UCAR European Representative

    9:40 – 10:10

    BioVaxys Technology Corp. (OTCQB:BVAXF) (CSE:BIOV)

    Keynote speaker: James Passin, CEO

    10:15 – 10:45

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    10:50 - 11:20

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    11:25 - 11:55

    Windtree Therapeutics, Inc. (NASDAQ:WINT)

    Keynote speaker: Craig Fraser, President & CEO

      

    12:00 - 12:30

    Longeveron, Inc. (NASDAQ:LGVN)

    Keynote speaker: Mohamed Wa'el Hashad, CEO & Director

    12:35 - 1:05

    Bioxytran, Inc. (OTCQB:BIXT)

    Keynote speakers: David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    1:10 - 1:40

    Nova Minerals Limited (NASDAQ:NVA) (OTC:NVAAF) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    1:45 - 2:15

    Innovotech, Inc. (TSXV:IOT)

    Keynote speaker: Craig Milne, CEO

    2:55 – 3:05

    Stuhini Explorations, Ltd. (OTCQB:STXPF) (TSXV:STU)

    Keynote speaker: David O'Brien, President & CEO

    3:10 - 3:20

    Atara Biotherapeutics, Inc. (NASDAQ:ATRA)

    Keynote speaker: Jason Awe, Head of Corporate Communications & IR

    3:25 - 3:35

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest – CEO

    3:40 – 3:50

    Interstellar Communication Holdings 

    Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard  of IcMercury, and Lijie Zhu, Captain of icMercury

    3:55 – 4:20

    Cannabis Bioscience International Holdings Inc. (OTC:CBIH)

    Keynote speakers: Dante Picaso, President / CEO

    4:25 – 4:55

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • When is the Emerging Growth Conference scheduled to occur?

      The conference will take place on December 4 and 5, 2024.

    • What is the purpose of the Emerging Growth Conference?

      The Emerging Growth Conference focuses on identifying companies in various growth sectors that exhibit strong management, innovative products, and a focus on long-term growth potential.

    • How can attendees register for the Emerging Growth Conference?

      Participants can register for the conference by clicking the provided registration link. There is an option for those who have already registered to enter their email to confirm their registration.

    • How can attendees ask questions to the presenting companies?

      Attendees can submit questions for any of the presenting companies by sending an email to [email protected].

    • What is the background of EmergingGrowth.com?

      EmergingGrowth.com was founded in 2009 and specializes in identifying emerging growth companies that may be overlooked by the investment community.

    Recent Analyst Ratings for
    $AEMD
    $ASPI
    $ATRA
    $BENF

    CompanyDatePrice TargetRatingAnalyst
    Atara Biotherapeutics Inc.
    $ATRA
    1/13/2026$6.00Buy → Hold
    Canaccord Genuity
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    Sky Harbour Group Corporation
    $SKYH
    10/27/2025$13.00Buy
    BTIG Research
    MetaVia Inc.
    $MTVA
    9/4/2025$12.00Buy
    H.C. Wainwright
    Aethlon Medical Inc.
    $AEMD
    7/7/2025$1.50Neutral
    H.C. Wainwright
    Sky Harbour Group Corporation
    $SKYH
    6/9/2025$14.00Buy
    Lake Street
    Sky Harbour Group Corporation
    $SKYH
    5/12/2025$23.00Outperform
    Noble Capital Markets
    Sky Harbour Group Corporation
    $SKYH
    4/25/2025$14.50Buy
    Alliance Global Partners
    More analyst ratings

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    Large owner Panacea Innovation Ltd bought $670,422 worth of shares (55,000 units at $12.19) (SEC Form 4)

    4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)

    8/19/25 8:15:04 PM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO Smith Ryan Lewis bought $2,340 worth of shares (2,000 units at $1.17), increasing direct ownership by 0.17% to 1,179,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    8/14/25 7:00:13 AM ET
    $USEG
    Oil & Gas Production
    Energy

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kozlowski Daniel R was granted 2,653 shares, increasing direct ownership by 0.76% to 351,210 units (SEC Form 4)

    4 - PURE CYCLE CORP (0000276720) (Issuer)

    1/16/26 2:07:34 PM ET
    $PCYO
    Water Supply
    Utilities

    Director Abel Wanda J was granted 2,653 shares, increasing direct ownership by 25% to 13,258 units (SEC Form 4)

    4 - PURE CYCLE CORP (0000276720) (Issuer)

    1/15/26 5:54:26 PM ET
    $PCYO
    Water Supply
    Utilities

    Director Roller Daniel J was granted 2,653 shares (SEC Form 4)

    4 - PURE CYCLE CORP (0000276720) (Issuer)

    1/15/26 4:57:43 PM ET
    $PCYO
    Water Supply
    Utilities

    $AEMD
    $ASPI
    $ATRA
    $BENF
    SEC Filings

    View All

    SEC Form 424B3 filed by Aethlon Medical Inc.

    424B3 - AETHLON MEDICAL INC (0000882291) (Filer)

    1/16/26 5:14:05 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Aethlon Medical Inc.

    DEF 14A - AETHLON MEDICAL INC (0000882291) (Filer)

    1/16/26 4:15:44 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    MetaVia Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - MetaVia Inc. (0001638287) (Filer)

    1/16/26 4:05:21 PM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Atara Biotherapeutics downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Atara Biotherapeutics from Buy to Hold and set a new price target of $6.00

    1/13/26 10:16:38 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    BTIG Research initiated coverage on Sky Harbour with a new price target

    BTIG Research initiated coverage of Sky Harbour with a rating of Buy and set a new price target of $13.00

    10/27/25 8:48:57 AM ET
    $SKYH
    Real Estate
    Finance

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option

    CAMBRIDGE, Mass., Jan. 16, 2026 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the closing of its previously announced underwritten public offering of Class A Units and Class B Units for gross proceeds of approximately $9.3 million, prior to deducting underwriting discounts and commissions and offering expenses and excluding any potential future proceeds from the exercise of warrants, which includes the full exercise of the underwriter's over-allotment option to purchase additional shares and warrants.

    1/16/26 4:01:00 PM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering

    CAMBRIDGE, Mass., Jan. 15, 2026 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA) (MetaVia or the Company), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the pricing of its underwritten public offering of shares of common stock (or common stock equivalents) and Series C Warrants and Series D Warrants for gross proceeds of approximately $8.1 million, prior to deducting underwriting discounts and commissions and offering expenses and excluding any potential future proceeds from the exercise of warrants. The underwritten public

    1/15/26 9:32:00 AM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pure Cycle Corporation Appoints Daniel J. Roller to its Board of Directors

    DENVER, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) ("Pure Cycle", "we", "us" or "our") announced that a new independent director, Daniel J. Roller, was appointed to its Board of Directors (the "Board"), effective January 14, 2026, expanding the Board from 7 to 8 directors. This appointment, made in cooperation with Maran Capital Management, LLC ("Maran"), which beneficially owns approximately 14.7% of Pure Cycle's common shares, further strengthens the Board and adds new skillsets and capabilities. In connection with this appointment, the Board will form a Strategy and Capital Allocation Committee, to be chaired by Mr. Roller. Mr. Roller, Presid

    1/15/26 8:30:00 AM ET
    $PCYO
    Water Supply
    Utilities

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Leadership Updates

    Live Leadership Updates

    View All

    Pure Cycle Corporation Appoints Daniel J. Roller to its Board of Directors

    DENVER, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) ("Pure Cycle", "we", "us" or "our") announced that a new independent director, Daniel J. Roller, was appointed to its Board of Directors (the "Board"), effective January 14, 2026, expanding the Board from 7 to 8 directors. This appointment, made in cooperation with Maran Capital Management, LLC ("Maran"), which beneficially owns approximately 14.7% of Pure Cycle's common shares, further strengthens the Board and adds new skillsets and capabilities. In connection with this appointment, the Board will form a Strategy and Capital Allocation Committee, to be chaired by Mr. Roller. Mr. Roller, Presid

    1/15/26 8:30:00 AM ET
    $PCYO
    Water Supply
    Utilities

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    Skyline Announces Change in Strategy, New Management and First Acquisition in Critical Minerals Space

    Hong Kong, Nov. 06, 2025 (GLOBE NEWSWIRE) --  -Appoints Paul Mann Executive Chairman to Lead New Strategic Direction for the Company  -Company makes first Acquisition in Critical Minerals Space Hong Kong, November 6, 2025 (GLOBE NEWSWIRE) – Skyline Builders Group Holding Limited (NASDAQ:SKBL), a Cayman Islands exempted company (the "Company"), today announced a number of strategic changes to the Company's leadership, strategy and corporate headquarters. Appointment of Paul Mann as Executive Chairman Effective January 1, 2026, Paul E. Mann will become Executive Chairman of the Company. Mr. Mann has a 25-year career as an investor and entrepreneur. He is currently the Founder and Executiv

    11/6/25 8:15:00 AM ET
    $ASPI
    $SKBL
    Major Chemicals
    Industrials
    Engineering & Construction
    Consumer Discretionary

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Financials

    Live finance-specific insights

    View All

    Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)

    U.S. Food and Drug Administration has issued a Complete Response Letter (CRL) Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the EBVALLO™ (tabelecleucel) Biologics License Application (BLA) as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at least one

    1/12/26 8:00:00 AM ET
    $ATRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Pure Cycle Announces Financial Results for the Three Months Ended November 30, 2025

    DENVER, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pure Cycle Corporation (NASDAQ Capital Market: PCYO) ("Pure Cycle", "we", "us" or "our") announced its financial results for the three months ended November 30, 2025. Pure Cycle reported $4.5 million of net income for the three months ended November 30, 2025, which is a 16% increase in net income from the same period in 2024 and marks the twenty-sixth consecutive fiscal quarter with positive net income. Pure Cycle reported $0.19 of earnings per fully diluted common share, which is up from $0.16 in the same period in 2024, a 19% increase. Pure Cycle continues to see demand for entry level lots at our Sky Ranch Master Planned Community despite nation

    1/7/26 4:00:00 PM ET
    $PCYO
    Water Supply
    Utilities

    Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates

    Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues) Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000 Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings WARRINGTON, Pa., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or "the Company") (OTCID: WINT), a diversified company with several divisions and focused on becoming

    12/23/25 9:00:00 AM ET
    $WINT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AEMD
    $ASPI
    $ATRA
    $BENF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Pure Cycle Corporation

    SC 13D/A - PURE CYCLE CORP (0000276720) (Subject)

    12/5/24 6:15:44 PM ET
    $PCYO
    Water Supply
    Utilities

    Amendment: SEC Form SC 13D/A filed by Brenmiller Energy Ltd

    SC 13D/A - Brenmiller Energy Ltd. (0001901215) (Subject)

    12/5/24 11:18:20 AM ET
    $BNRG
    Building Products
    Industrials

    SEC Form SC 13G filed by Icon Energy Corp.

    SC 13G - Icon Energy Corp (0001995574) (Subject)

    11/14/24 8:38:27 PM ET
    $ICON
    Marine Transportation
    Consumer Discretionary